Autopsy report · NCT06182410

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

“Industry sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Transplant-Associated Thrombotic Microangiopathy; Neuroblastoma; High-risk Neuroblastoma; Thrombotic Microangiopathies

Interventions

Defibrotide

Participants

0

Trials that died the same way

• Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
  “Sponsor decision” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.